When your thyroid is gone most patients are given T4 medications ONLY (remember that this is the INACTIVE hormone)
However, when the 5-HT-releasing agent D-fenfluramine is used in patients experiencing a neurobehavioral syndrome after exposure to organophosphates, elevated sensitivity of central 5-HT receptors is observed (442)
Imaging Studies: In some cases, a mammogram, ultrasound, or even an MRI may be recommended to further evaluate the breast tissue or look for underlying tumors
Key Takeaways Tirzepatide activates two incretin hormone pathways (GLP-1 and GIP)
Alternatively, a split dose (long-acting plus a small short-acting booster later) is something to discuss with your doctor
Dose titration decisions are made by the Arora Health clinician based on your clinical response - not by Trimi's platform, and not by you